More Than Half of U.S. Dog Owners Concerned About Pet Vaccines
The novel messenger RNA (mRNA) COVID-19 shots, notably Pfizer/BioNTech’s Comirnaty and Moderna/NIAID’s Spikevax biologics, were not he only shots causing millions of Americans to worry and be skeptical about their safety and efficacy over the past three years. A new study published last month in the journal Vaccine found that more than half of dog […]
First Postpartum Depression Drug Fast Tracked and Licensed by FDA
On Aug. 4, 2023, the U.S. Food and Drug Administration (FDA) fast tracked licensure of the oral prescription medication Zurzuvae (zuranolone), manufactured by Sage Therapeutics, Inc. as a treatment for postpartum depression. Postpartum affects roughly one in seven women and typically begins after childbirth but, for some women, it can begin during later stages of […]
First Over-the-Counter Birth Control Pill Approved by FDA
On July 13, 2023, the U.S. Food and Drug Administration (FDA) approved the first ever non-prescription birth control pill. The progestin-only oral contraceptive known as Opill (norgestrel) is expected to be available in pharmacies, supermarkets, and convenience stores by early 2024. Opill claims a 93 percent efficacy rate in pregnancy prevention.1 Norgestrel Originally Approved in […]
More Young Children Ingested Drugs and Illicit Substances During COVID Pandemic Period
A new study published in the Journal of the American Medical Association (JAMA) shows an increase in ingestion of illicit substances such as cannabis, opioids and ethanol among children under six years old in the COVID-19 pandemic period compared with the pre-pandemic period.1 “This is an important study, with a clear indication of the ongoing and […]
CDC Gives More Than $3 Billion to Local and State Health Departments
Officials at the U.S. Centers for Disease Control and Prevention (CDC) announced that they are distributing $3.2 billion to state, local, and territorial health departments across the United States in what they describe as an attempt to “strengthen” public health initiatives. CDC director Rochelle Walensky, MD said the money will give local agencies critical funding […]
Shortage of Adderall Affecting Behavior in Children and Adults
On October 12, 2022, the U.S. Food and Drug Administration (FDA) announced a shortage of a drug formulation of amphetamine mixed salts, commonly referred to by the brand name Adderall. Adderall is an FDA approved drug for the treatment of narcolepsy and attention deficit hyperactivity disorder (ADHD), including anger, anxiety, forgetfulness and trouble focusing.1 Adderall […]
